About Colospan
Colospan is a company based in Kfar Saba (Israel) founded in 2010. Colospan has raised $8 million across 4 funding rounds from investors including European Union, Clal Biotechnology Industries and Docor. Colospan offers products and services including CG-100. Colospan operates in a competitive market with competitors including Axonics, Averto Medical, Signum Surgical, Boomerang Medical and Exero Medical, among others.
- Headquarter Kfar Saba, Israel
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website colospan.com
- Total Equity Funding$8M (USD)
in 4 rounds
- Latest Funding Round$2.41M (USD), Grant
Jun 2022
- InvestorsEuropean Union
& 4 more
Products & Services of Colospan
Colospan offers a comprehensive portfolio of products and services, including CG-100.
Medical device for EU commercial and US investigational use.
Funding Insights of Colospan
Colospan has successfully raised a total of $8M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $2.41 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8M
- Total Rounds 4
- Last Round Grant — $2.41M
- First Round $52,086
(Jan 2017)
- Investors Count 5
All 4 funding rounds of Colospan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $2.41M | Grant | – | – | |
| Sep 2017 | $8M | Series A | – | Triventures | |
| Mar 2017 | $52,674 | Grant | – | – | |
| Jan 2017 | $52,086 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Colospan
Colospan has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Clal Biotechnology Industries and Docor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are directed toward Israeli technology startups by Docor. | – | docor.com | Tel Aviv, Israel | |
Life Sciences focused VC firm investing in Israel and the US | 1993 | cbi.co.il | Tel Aviv, Israel | |
Venture capital firm investing in early stage healthcare startups | – | triventures.vc | Herzliya, Israel | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
- | – | amitechnion.com | - |
Investor details for Colospan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Colospan
1 people are tracked at Colospan (1 in leadership).
| Name | Role | Group |
|---|---|---|
Boaz Assaf | CEO | Leadership |
Complete people profiles for Colospan
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Colospan
3 dated milestones of Colospan across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Colospan is founded.
- Funding First funding round of $52K.
- Funding Latest funding round, Grant, of $2.4M.
Competitors of Colospan
Colospan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Averto Medical, Signum Surgical, Boomerang Medical and Exero Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| axonics.com | 2013 | Irvine, United States | $143.47M | 762 | Sacral neuromodulation devices are developed for urinary and bowel control. | |
| avertomed.com | 2016 | Fremont, United States | $33M | 18 | Medical devices for gastrointestinal disease patients are developed. | |
| signumsurgical.com | 2014 | Galway, Ireland | $5.73M | – | Surgically implanted devices for perianal fistula treatment are provided. | |
| boomerangmedical.com | 2021 | Mountain View, United States | $35M | – | Bioelectronic devices are developed for autoimmune disease treatment. | |
| exeromedical.com | 2018 | Or Yehuda, Israel | $10M | – | Develoepr of a sensor device for early detection of anastomotic leaks | |
| mowoot.com | 2014 | Barcelona, Spain | $3.98M | – | A non-invasive medical device for chronic constipation treatment is developed. | |
| spirusmedllc.com | 2005 | West Bridgewater, United States | $15.24M | – | Spiral over-tubes and steerable introducers for GI endoscopy are provided. | |
| ostomycure.com | 2004 | Oslo, Norway | – | – | Develops innovative stoma management solutions for ileostomy patients through clinical trials. | |
| novogi.com | 1996 | Netanya, Israel | $18.5M | – | Provides compression anastomosis devices for GI disease management. | |
| tytex.com | 1996 | Ikast, Denmark | – | 583 | Specialized apparels for continence, post-surgery, and wound care are produced. |
Detailed competitors of Colospan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Colospan
Complete news archive for Colospan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Colospan
10 companies that operate in the same segment as Colospan (Gastroenterology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Implantable battery-powered pumps for ascites removal are developed. | 2006 | Zurich, Switzerland | USD 35.5 M | – | – | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | – | – | |
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | – | 533 | |
Developer of electrosurgical system and range of flexible endoscopic instruments | 2003 | Chepstow, Monmouthshire, United Kingdom | USD 20.84 M | USD 8.08 M | 141 | |
Non-invasive biomarker tests for colorectal cancer are developed. | 2015 | St. Louis, Missouri, United States | USD 218.95 M | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed. | 2007 | Fremont, California, United States | USD 61.1 M | USD 407.32 M | 395 | |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases | 2009 | Ramat Gan, Tel Aviv District, Israel | USD 13.5 M | USD 288.27 K | 35 | |
Biologics are developed for cardio-metabolic and liver diseases. | 2007 | San Francisco, California, United States | USD 358.87 M | USD 330.53 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Colospan
Colospan was founded in 2010 and raised its 1st funding round 7 years after it was founded.
Colospan is headquartered in Kfar Saba, Israel. It is registered at Kfar Saba, Central District, Israel.
Boaz Assaf is the current CEO of Colospan.
Colospan is a funded company, having raised a total of $8M across 4 funding rounds to date. The company's 1st funding round was a Grant of $52.09K, raised on Jan 2017.
Colospan was founded in 2010 and is based in Kfar Saba, Israel. Operations are focused on the medical device sector, where intraluminal bypass devices are developed to address complications in colorectal surgery. The company is led by CEO Boaz Assaf. Activities center on innovation in surgical technologies, with efforts directed toward improving patient outcomes through targeted device solutions in the gastrointestinal field.
Colospan's top competitors include Axonics, Signum Surgical and Exero Medical.
Colospan offers CG-100.
Colospan has 5 investors. Key investors include European Union, Clal Biotechnology Industries, Docor, AmiTechnion, and Triventures.